The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice

BACKGROUND: The hallmark of Type 2 diabetes (T2D) is hyperglycemia, although there are multiple other metabolic abnormalities that occur with T2D, including insulin resistance and dyslipidemia. To advance T2D prevention and develop targeted therapies for its treatment, a greater understanding of the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nutr Metab (Lond)
Asıl Yazarlar: Kumar, Amit, Shiloach, Joseph, Betenbaugh, Michael J, Gallagher, Emily J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362840/
https://ncbi.nlm.nih.gov/pubmed/25784953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-015-0003-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller